Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 44,053 $ 62,632
Equity method investments 3,353,224 2,966,305
Receivables, net of allowance of $49 million and $50 million, respectively 2,899,707 3,073,855
Receivables held-for-sale 22,183 35,299
Real estate 2,987 111,036
Investments 17,576 7,165
Securitization assets, net of allowance of $3 million and $3 million, respectively 257,537 218,946
Other assets 75,257 77,112
Total Assets 6,672,524 6,552,350
Liabilities:    
Accounts payable, accrued expenses and other 218,844 163,305
Credit facilities 116,388 400,861
Commercial paper notes 18,265 30,196
Term loans payable 412,309 727,458
Senior unsecured notes 2,840,077 2,318,841
Convertible notes 613,195 609,608
Total Liabilities 4,349,425 4,410,725
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 118,194,568 and 112,174,279 shares issued and outstanding, respectively 1,182 1,122
Additional paid-in capital 2,567,654 2,381,510
Accumulated deficit (318,084) (303,536)
Accumulated other comprehensive income (loss) 7,537 13,165
Non-controlling interest 64,810 49,364
Total Stockholders’ Equity 2,323,099 2,141,625
Total Liabilities and Stockholders’ Equity 6,672,524 6,552,350
Non-recourse debt    
Liabilities:    
Non-recourse debt (secured by assets of $302 million and $239 million, respectively) 130,347 160,456
Collateral pledged | Non-recourse debt    
Assets    
Total Assets $ 302,000 $ 239,000